Analyst Activity – Canaccord Genuity Reiterates Buy on Edwards Lifesciences (NYSE:EW)

ME Staff
-
0

Analyst Ratings For Edwards Lifesciences (NYSE:EW)

Today, Canaccord Genuity reiterated its Buy rating on Edwards Lifesciences (NYSE:EW) with a price target of $174.00.

Some recent analyst ratings include

  • 2/2/2018-Canaccord Genuity Reiterated Rating of Buy.
  • 2/1/2018-Cowen Reiterated Rating of Buy.
  • 1/31/2018-SunTrust Banks Reiterated Rating of Buy.
  • 1/4/2018-Barclays Upgrade from a “Equal Weight ” rating to a ” Overweight” rating.
  • 1/3/2018-Evercore ISI initiated coverage with a Outperform rating.
  • 1/2/2018-JPMorgan Chase & Co. was Downgraded by analysts at JPMorgan Chase & Co. from a “Overweight ” rating to a ” Neutral” rating.
  • 12/8/2017-BMO Capital Markets Reiterated Rating of Buy.

Recent Insider Trading Activity For Edwards Lifesciences (NYSE:EW)
Edwards Lifesciences (NYSE:EW) has insider ownership of 2.13% and institutional ownership of 81.78%.

  • On 12/28/2018 Donald E. Bobo, Jr., VP, sold 5,300 with an average share price of $114.08 per share and the total transaction amounting to $604,624.00.
  • On 1/29/2018 Donald E Bobo Jr, VP, sold 5,300 with an average share price of $127.24 per share and the total transaction amounting to $674,372.00.
  • On 1/16/2018 Larry L Wood, VP, sold 6,300 with an average share price of $121.00 per share and the total transaction amounting to $762,300.00.
  • On 1/4/2018 Michael A. Mussallem, CEO, sold 32,800 with an average share price of $114.97 per share and the total transaction amounting to $3,771,016.00.
  • On 12/28/2017 Donald E. Bobo, Jr., VP, sold 5,300 with an average share price of $114.08 per share and the total transaction amounting to $604,624.00.
  • On 12/19/2017 Michael A. Mussallem, CEO, sold 32,800 with an average share price of $114.82 per share and the total transaction amounting to $3,766,096.00.
  • On 12/15/2017 Larry L. Wood, VP, sold 18,960 with an average share price of $114.58 per share and the total transaction amounting to $2,172,436.80.

Recent Trading Activity for Edwards Lifesciences (NYSE:EW)
Shares of Edwards Lifesciences closed the previous trading session at 136.07 up +9.09 7.16% with shares trading hands.